| Health / Medical Topics |
Ponezumab
A humanized monoclonal antibody (IgG2deltaA) raised against amyloid beta peptides with Alzheimer disease treatment application. Ponezumab recognizes and binds the free carboxy terminal amino acids 33-40 of the amyloid beta peptide 1-40 and may be used in a passive immunotherapy treatment. (NCI Thesaurus)
YOU MAY ALSO LIKE
A drug used to treat chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia. It is used in patients who are…
An orally bioavailable multitargeted receptor tyrosine kinase (RTK) inhibitor with potential antiangiogenic and antineoplastic activities. Ponatinib inhibits unmutated and all mutated forms…
The Pomeranian is a tiny dog with a wedge-shaped head and pointed erect ears. The profuse stand-off double coat includes an abundant…
A pill formulation of polyphenol extracts derived from the fruit of the deciduous shrub Punica granatum with antioxidant and potential chemopreventive…
The oil extracted from the seeds of Punica granatum. Pomegranite seed oil is a source of antioxidants and is used in skincare…
A liquid extract preparation derived from pomegranate (Punica granatum) seeds with antioxidant, and potential antineoplastic and chemopreventive activities. Pomegranate liquid extract contains…
